메뉴 건너뛰기




Volumn 56, Issue 4, 2002, Pages 267-271

14. Breast cancer prevention

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; ARZOXIFENE; BISPHOSPHONIC ACID DERIVATIVE; BRCA1 PROTEIN; BRCA2 PROTEIN; ESTROGEN RECEPTOR; GONADORELIN DERIVATIVE; LETROZOLE; ORAL CONTRACEPTIVE AGENT; PLACEBO; POLYAMINE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

EID: 0036279218     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (4)

References (29)
  • 6
    • 0032508294 scopus 로고    scopus 로고
    • Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial
    • (1998) Lancet , vol.352 , pp. 98-101
    • Powles, T.1    Eeles, R.2    Ashley, S.3
  • 13
    • 0034162552 scopus 로고    scopus 로고
    • Association between energy balance and body mass index and risk of breast cancer in women from diverse racial and ethnic background in the US
    • (2000) Cancer , vol.88 , pp. 1248-1255
    • McTiernan, A.1
  • 18
    • 0030843969 scopus 로고    scopus 로고
    • Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
    • Collaborative Group on Hormonal Factors in Breast Cancer
    • (1997) Lancet , vol.350 , pp. 1047-1059
  • 19
    • 0003185814 scopus 로고    scopus 로고
    • Breast cancer and hormonal contraceptive: Further results
    • Collaboration Group on Hormonal Factors in Breast Cancer
    • (1996) Contraception , vol.54


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.